Genetic association of in and in with the risk of breast cancer in the North Indian population: a case–control study

Chen C, Huang Y, Li Y, Mao Y, Xie Y. Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk: a meta-analysis. J Hum Genet. 2007;52(5):423. https://doi.org/10.1007/s10038-007-0131-8.

Article  PubMed  CAS  Google Scholar 

Deligezer U, Akisik EE, Dalay N. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In vivo. 2005;19(5):889–93.

PubMed  CAS  Google Scholar 

DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019). Breast cancer statistics, 2019. CA: a cancer journal for clinicians, 69(6), 438–451. https://doi.org/10.3322/caac.21583

Devi, S., Raina, J. K., Kumar, P., Sudershan, A., Sharma, R., Panjalyia, R. K., ... & Kumar, P. (2023). Genetic association study of rs1801133 of MTHFR, rs4646903 of CYP1A1, null mutation of GSTM1 & GSTT1 with leukemia in the Jammu region of north Indian population. The Nucleus, 1–12.

Ergul E, Sazci A, Utkan Z, Canturk NZ. Polymorphisms in the MTHFR gene are associated with breast cancer. Tumor biology. 2004;24(6):286–90.

Article  Google Scholar 

Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994;7(2):195–200. https://doi.org/10.1038/ng0694-195.

Article  PubMed  CAS  Google Scholar 

Hekim N, Ergen A, Yaylım İ, Yılmaz H, Zeybek Ü, Öztürk O, İsbir T. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem Funct. 2007;25(1):115–7.

Article  PubMed  CAS  Google Scholar 

Kaya EF, Karakus N, Ulusoy AN, Özaslan C, Kara N. Association of the MTHFR gene C677T polymorphism with breast cancer in a Turkish population. Oncology research and treatment. 2016;39(9):534–8.

Article  PubMed  CAS  Google Scholar 

Khalili G, Barzegar A, Nikbakhsh N, Ansari-Pirsaraee Z. Study of Cytochrome P450 1A1 (T3801C) single nucleotide polymorphism in patients with breast cancer in mazandaran province-northern Iran. Research in Molecular Medicine. 2015;3(4):17–22.

CAS  Google Scholar 

Leclerc D, Rozen R. Génétiquemoléculaire de MTHFR: les polymorphismes ne sont pas tousbénins [Molecular genetics of MTHFR: polymorphisms are not all benign]. Medecinesciences : M/S. 2007;23(3):297–302. https://doi.org/10.1051/medsci/2007233297.

Article  Google Scholar 

Li, Z., Zhang, J., Zou, W., Xu, Q., Li, S., Wu, J., ... & Chen, C. (2021). The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with breast cancer subtype susceptibility in southwestern China. Plos one, 16(7), e0254267.

Lievers KJ, Boers GH, Verhoef P, den Heijer M, Kluijtmans LA, van der Put NM, Trijbels FJ, Blom HJ. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med (Berl). 2001;79(9):522–8. https://doi.org/10.1007/s001090100253.

Article  PubMed  CAS  Google Scholar 

Lin, W. Y., Chou, Y. C., Wu, M. H., Huang, H. B., Jeng, Y. L., Wu, C. C., ... & Sun, C. A. (2004). The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: a nested case-control study in Taiwan. Anticancer research, 24(6), 3863–3868.

Madhav, M. R., Nayagam, S. G., Biyani, K., Pandey, V., Kamal, D. G., Sabarimurugan, S., Ramesh, N., Gothandam, K. M., &Jayaraj, R. (2018). Epidemiologic analysis of breast cancer incidence, prevalence, and mortality in India: Protocol for a systematic review and meta-analyses. Medicine, 97(52), e13680.https://doi.org/10.1097/MD.0000000000013680

Mohammadzadeh G, Karimi M, Bazyar M, Hosseini SM. Lack of association between MTHFR C677T polymorphism and breast cancer risk in Ahvaz, west south-Iran. Adv Biomed Res. 2016;5(1):26.

Article  PubMed  PubMed Central  Google Scholar 

Moreno-Galván M, Herrera-González NE, Robles-Pérez V, Velasco-Rodríguez JC, Tapia-Conyer R, Sarti E. Impact of CYP1A1 and COMT genotypes on breast cancer risk in Mexican women: a pilot study. Int J Biol Markers. 2010;25(3):157–63. https://doi.org/10.1177/172460081002500306.

Article  PubMed  Google Scholar 

Naif HM, Al-Obaide MA, Hassani HH, Hamdan AS, Kalaf ZS. Association of cytochrome CYP1A1 gene polymorphisms and tobacco smoking with the risk of breast cancer in women from Iraq. Front Public Health. 2018;6:96.

Article  PubMed  PubMed Central  Google Scholar 

Rezende LM, Marson FAL, Lima CSP, Bertuzzo CS. Can MTHFR C677T and A1298C polymorphisms alter the risk and severity of sporadic breast cancer in Brazilian women? Clin Breast Cancer. 2017;17(4):e199–208.

Article  PubMed  CAS  Google Scholar 

Sharma R, Raina JK, Azad T, Kumar P, Panjaliya RK. Methylenetetrahydrofolate reductase (MTHFR) and angiotensin converting enzyme (ACE) gene variations in link with breast cancer in Jammu Region of Jammu and Kashmir state. Int J Hum Genet. 2018;18(3):219–27.

Google Scholar 

Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Breast Cancer Res Treat. 2007;101:73–81.

Article  PubMed  CAS  Google Scholar 

Škovierová H, Vidomanová E, Mahmood S, Sopková J, Drgová A, Červeňová T, Halašová E, Lehotský J. The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health. Int J Mol Sci. 2016;17(10):1733. https://doi.org/10.3390/ijms17101733.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sudershan A, Mahajan K, Panjaliya RK, Dhar MK, Kumar P. Algorithm for sample availability prediction in a hospital-based epidemiological study spreadsheet-based sample availability calculator. Sci Rep. 2022;12(1):1860. https://doi.org/10.1038/s41598-021-03399-1.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sudershan A, Pushap AC, Kumar H, Kumar P. A Comprehensive Investigation into the Association Between Mthfr C677T, A1298c, and Ace I/D Variants and Risk of Migraine: an Updated Meta-Analysis of Genetic Association Studies with Trial Sequential Analysis and Meta-Regression. Journal of molecular neuroscience : MN. 2023;73(11–12):884–911. https://doi.org/10.1007/s12031-023-02164-5.

Article  PubMed  CAS  Google Scholar 

Waseem, M., Hussain, S. R., Kumar, S., Serajuddin, M., Mahdi, F., Sonkar, S. K., ... & Ahmad, M. K. (2016). Association of MTHFR (C677T) gene polymorphism with breast cancer in North India. Biomarkers in cancer, 8, BIC-S40446.

Weiwei, Z., Liping, C., & Dequan, L. (2014). Association between dietary intake of folate, vitamin B6, B12 & MTHFR, MTR Genotype and breast cancer risk. Pakistan journal of medical sciences, 30(1), 106–110. https://doi.org/10.12669/pjms.301.4189

Yang C, He XF. Evaluation of association studies and a systematic review and meta-analysis of CYP1A1 T3801C and A2455G polymorphisms in breast cancer risk. PLoS ONE. 2021;16(4): e0249632. https://doi.org/10.1371/journal.pone.0249632.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yao L, Yu X, Yu L. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects. Breast Cancer Res Treat. 2010;122(2):503–7. https://doi.org/10.1007/s10549-009-0717-2.

Article  PubMed  CAS  Google Scholar 

Comments (0)

No login
gif